LabGenomics (Korea) Top Management

084650 Stock  KRW 2,770  20.00  0.73%   
Analysis of LabGenomics' management performance can provide insight into the company performance.
Sung Chin  Insider
Chief Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LabGenomics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

LabGenomics Management Team Effectiveness

The company has return on total asset (ROA) of 0.4648 % which means that it generated a profit of $0.4648 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 42.8159 %, meaning that it generated $42.8159 on every $100 dollars invested by stockholders. LabGenomics' management efficiency ratios could be used to measure how well LabGenomics manages its routine affairs as well as how well it operates its assets and liabilities.

LabGenomics Workforce Comparison

LabGenomics Co is rated second in number of employees category among related companies. The total workforce of Healthcare Providers & Services industry is presently estimated at about 466. LabGenomics totals roughly 233 in number of employees claiming about 50% of equities under Healthcare Providers & Services industry.
The company has Profit Margin (PM) of 0.38 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.48 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.48.

LabGenomics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. LabGenomics Price Series Summation is a cross summation of LabGenomics price series and its benchmark/peer.

LabGenomics Stakeholder

Sung ChinChief OfficerProfile

About LabGenomics Management Performance

The success or failure of an entity such as LabGenomics often depends on how effective the management is. LabGenomics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LabGenomics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LabGenomics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The data published in LabGenomics' official financial statements usually reflect LabGenomics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of LabGenomics. For example, before you start analyzing numbers published by LabGenomics accountants, it's critical to develop an understanding of what LabGenomics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of LabGenomics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LabGenomics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in LabGenomics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LabGenomics Co. Please utilize our Beneish M Score to check the likelihood of LabGenomics' management manipulating its earnings.

LabGenomics Workforce Analysis

Traditionally, organizations such as LabGenomics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LabGenomics within its industry.

LabGenomics Manpower Efficiency

Return on LabGenomics Manpower

Revenue Per Employee868.7M
Net Income Per Employee359.9M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LabGenomics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the LabGenomics information on this page should be used as a complementary analysis to other LabGenomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for LabGenomics Stock analysis

When running LabGenomics' price analysis, check to measure LabGenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LabGenomics is operating at the current time. Most of LabGenomics' value examination focuses on studying past and present price action to predict the probability of LabGenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LabGenomics' price. Additionally, you may evaluate how the addition of LabGenomics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Please note, there is a significant difference between LabGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if LabGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LabGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.